Mon, December 5, 2022
Sun, December 4, 2022
Fri, December 2, 2022
Thu, December 1, 2022
Wed, November 30, 2022
Tue, November 29, 2022
Mon, November 28, 2022
Fri, November 25, 2022
Thu, November 24, 2022
Wed, November 23, 2022

Amit Hazan Maintained (BVS) at Hold with Decreased Target to $2.5 on, Nov 30th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-2-5-on-nov-30th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Amit Hazan of Goldman Sachs, Maintained "Bioventus Inc." (BVS) at Hold with Decreased Target from $13 to $2.5 on, Nov 30th, 2022.

Amit has made no other calls on BVS in the last 4 months.



There are 4 other peers that have a rating on BVS. Out of the 4 peers that are also analyzing BVS, 2 agree with Amit's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Alexander Nowak of "Craig-Hallum" Downgraded from Strong Buy to Hold on, Tuesday, November 22nd, 2022
  • Kyle Rose of "Canaccord Genuity" Downgraded from Strong Buy to Hold on, Wednesday, November 9th, 2022


These are the ratings of the 2 analyists that currently disagree with Amit


  • Drew Ranieri of "Morgan Stanley" Maintained at Buy with Decreased Target to $5 on, Thursday, November 10th, 2022
  • Robbie Marcus of "JP Morgan" Downgraded from Buy to Sell on, Wednesday, November 9th, 2022

Publication Contributing Sources